Publication | Closed Access

Drug-Related Pneumonitis Induced by Osimertinib as First-Line Treatment for Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer

Drug-related Pneumonitis InducedOncologyPerineural InvasionMedicinePathologyBronchial NeoplasmFirst-line TreatmentCancer TreatmentLung CancerPharmacologyCancer GrowthTumor MicroenvironmentCancer Research